| Bioactivity | CREKA peptide is a short peptide sequence, belonging to self-assembling peptides (SAPs), which can self-assemble into functional nanostructures, typically nanofibers, under physiological conditions. CREKA peptide can be used to target tumor cells and tumor vasculature, exhibiting antitumor activity[1]. |
| CAS | 847058-45-1 |
| Sequence | Cys-Arg-Glu-Lys-Ala |
| Shortening | CREKA |
| Formula | C23H43N9O8S |
| Molar Mass | 605.71 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhang N, et al. Recent advances of CREKA peptide-based nanoplatforms in biomedical applications. J Nanobiotechnology. 2023 Mar 3;21(1):77. |
CREKA peptide
CAS: 847058-45-1 F: C23H43N9O8S W: 605.71
CREKA peptide is a short peptide sequence, belonging to self-assembling peptides (SAPs), which can self-assemble into fu
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.